Authors
Loading...
Preclinical study reveals reduced growth and metastasis in multidrug-resistant liver tumors using an albumin-bound palladium agent, suggesting an effective strategy to counter drug resistance.
Jiang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: